Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 72
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Medicina (Kaunas) ; 58(6)2022 May 26.
Artículo en Inglés | MEDLINE | ID: mdl-35743973

RESUMEN

Background and Objectives: Kruppel-like factor 10 (KLF10) participates in the tumorigenesis of several human cancers by binding to the GC-rich region within the promoter regions of specific genes. KLF10 is downregulated in human cancers. However, the role of KLF10 in gastric cancer formation remains unclear. Materials and Methods: In this study, we performed immunohistochemical staining for KLF10 expression in 121 gastric cancer sections. Results: The loss of KLF10 expression was correlated with advanced stages and T status. Kaplan-Meier analysis revealed that patients with higher KLF10 levels had longer overall survival than those with lower KLF10 levels. Univariate analysis revealed that in patients with gastric cancer, advanced stages and low KLF10 levels were associated with survival. Multivariate analysis indicated that age, gender, advanced stages, and KLF10 expression were independent prognostic factors of the survival of patients with gastric cancer. After adjusting for age, gender, and stage, KLF10 expression was also found to be an independent prognostic factor in the survival of patients with gastric cancer. Conclusion: Our results collectively suggested that KLF10 may play a critical role in gastric cancer formation and is an independent prognosis factor of gastric cancer.


Asunto(s)
Factores de Transcripción de la Respuesta de Crecimiento Precoz , Neoplasias Gástricas , Transformación Celular Neoplásica , Factores de Transcripción de la Respuesta de Crecimiento Precoz/genética , Factores de Transcripción de la Respuesta de Crecimiento Precoz/metabolismo , Humanos , Factores de Transcripción de Tipo Kruppel/genética , Factores de Transcripción de Tipo Kruppel/metabolismo , Pronóstico , Neoplasias Gástricas/genética
2.
Gastroenterology ; 151(3): 472-480.e1, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-27269245

RESUMEN

BACKGROUND & AIMS: The incidence of hepatocellular carcinoma (HCC) increases with age, but protective antibody responses decrease with time after infants are immunized against hepatitis B virus (HBV). We investigated whether immunization of infants against HBV prevents their developing HCC as adults. We also searched for strategies to maximize the cancer-preventive effects. METHODS: We collected data from 2 Taiwan HCC registry systems on 1509 patients (6-26 years old) diagnosed with HCC from 1983 through 2011. Data on history of HBV immunization and prenatal maternal levels of HBV antigens of all HCC patients born after July 1984 were retrieved from the HBV immunization data bank of the Taiwan Center for Disease Control. We collected data on birth cohort-specific populations (6-26 years old) of Taiwan using the National Household Registry System. Rates of HCC incidence per 10(5) person-years were derived by dividing the number of patients with HCC by the person-years of the general population. Relative risks (RR) for HCC were estimated by Poisson regression analysis in vaccinated vs unvaccinated birth cohorts. We stratified patients by age group to evaluate the association of birth cohorts and HCC risks. RESULTS: Of the 1509 patients with HCC, 1343 were born before, and 166 were born after, the HBV vaccination program began. HCC incidence per 10(5) person-years was 0.92 in the unvaccinated cohort and 0.23 in the vaccinated birth cohorts. The RRs for HCC in patients 6-9 years old, 10-14 years old, 15-19 years old, and 20-26 years old who were vaccinated vs unvaccinated were 0.26 (95% confidence interval [CI], 0.17-0.40), 0.34 (95% CI, 0.25-0.48), 0.37 (95% CI, 0.25-0.51), and 0.42 (95% CI, 0.32-0.56), respectively. The RR for HCC in 6- to 26-year-olds was lower in the later vs the earlier cohorts (born in 1992-2005 vs 1986-1992; P < .001 and 1986-1992 vs 1984-1986; P < .002). Transmission of HBV from highly infectious mothers and incomplete immunization were associated with development of HCC. CONCLUSIONS: Based on an analysis of 1509 patients with HCC in Taiwan, immunization of infants against HBV reduces their risk of developing HCC as children and young adults. Improving HBV vaccination strategies and overcoming risk factors could reduce the incidence of liver cancer.


Asunto(s)
Carcinoma Hepatocelular/prevención & control , Vacunas contra Hepatitis B/administración & dosificación , Neoplasias Hepáticas/prevención & control , Vacunación/estadística & datos numéricos , Adolescente , Adulto , Factores de Edad , Carcinoma Hepatocelular/epidemiología , Carcinoma Hepatocelular/virología , Niño , Femenino , Hepatitis B/prevención & control , Humanos , Incidencia , Neoplasias Hepáticas/epidemiología , Neoplasias Hepáticas/virología , Masculino , Sistema de Registros , Análisis de Regresión , Factores de Riesgo , Taiwán/epidemiología , Tiempo , Vacunación/métodos , Adulto Joven
3.
Ann Diagn Pathol ; 18(2): 74-7, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24461703

RESUMEN

Kruppel-like factor 8 (KLF8) is important in cell proliferation, epithelial-to-mesenchymal transition, cell migration, and invasion. Gastric adenocarcinoma is among the leading causes of cancer-related death in the world. In this study, the clinicopathologic correlation of KLF8 expression with gastric adenocarcinoma in Taiwan was investigated. The nuclear localization of KLF8 was correlated with advanced stage (P = .008) and 3-year survival rate (P = .043). The nuclear expression of KLF8 was significantly higher in the diffused type of gastric adenocarcinoma compared with the intestinal type (P = .036). Kaplan-Meier analysis results showed that patients with positive nuclear KLF8 had significantly lower overall survival rate compared with those with negative nuclear KLF8 (P = .011). Univariate analysis results indicated that positive nuclear KLF8 expression, advanced stage, and lymph node metastasis are correlated with lower overall survival. Positive nuclear KLF8 might be correlated with lower survival in gastric adenocarcinoma patients and might be an oncogene property in gastric adenocarcinoma carcinogenesis.


Asunto(s)
Adenocarcinoma/metabolismo , Biomarcadores de Tumor/metabolismo , Proteínas Represoras/metabolismo , Neoplasias Gástricas/metabolismo , Adenocarcinoma/mortalidad , Adenocarcinoma/patología , Adulto , Anciano , Anciano de 80 o más Años , Núcleo Celular/metabolismo , Proliferación Celular , Femenino , Humanos , Estimación de Kaplan-Meier , Factores de Transcripción de Tipo Kruppel , Metástasis Linfática , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Pronóstico , Neoplasias Gástricas/mortalidad , Neoplasias Gástricas/patología , Tasa de Supervivencia , Taiwán/epidemiología , Análisis de Matrices Tisulares
4.
Telemed J E Health ; 20(2): 175-8, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24320193

RESUMEN

OBJECTIVE: To investigate the effectiveness of shared care combined with telecare in type 2 diabetic patients in an underserved community in Asia. RESEARCH DESIGN AND METHODS: In total, 95 patients with type 2 diabetes who had a glycosylated hemoglobin (HbA1c) level of >7% were recruited from six community health centers in remote areas in Changhua County, Taiwan. All patients were randomly divided into intervention (shared care combined with telecare) and usual-care groups and followed up for 6 months. RESULTS: The decrease in HbA1c level was significantly greater in the intervention group than in the usual-care group (0.7 ± 1.3% versus 0.1 ± 1.0%, p=0.03). There were no significant differences in lipid profiles and blood pressure changes between the two groups. CONCLUSIONS: Shared care combined with telecare could significantly reduce HbA1c levels in type 2 diabetic patients with poor glycemic control in underserved rural communities. Further studies should be conducted to clarify the target users and to develop cost-effective interventions.


Asunto(s)
Diabetes Mellitus Tipo 2/terapia , Grupo de Atención al Paciente , Telemedicina/métodos , Glucemia/análisis , Diabetes Mellitus Tipo 2/sangre , Femenino , Hemoglobina Glucada/análisis , Accesibilidad a los Servicios de Salud , Humanos , Masculino , Área sin Atención Médica , Persona de Mediana Edad , Población Rural , Taiwán
5.
Eur J Clin Invest ; 43(9): 949-56, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23879740

RESUMEN

BACKGROUND: Although the association between chronic Helicobacter pylori infection and type 2 diabetes has been suggested, findings have been inconsistent. This study evaluated the association between chronic H. pylori infection and glucose regulation. MATERIALS AND METHODS: We evaluated H. pylori infection status of participants recruited from the gastroenterology clinic at our hospital. At baseline, we performed blood tests including fasting plasma glucose, insulin, glycated haemoglobin A1c (HbA1c) and other biochemical measurements. Insulin resistance and beta-cell function were assessed by homoeostasis model assessment (HOMA-IR and HOMA-B, respectively). RESULTS: A total of 2070 participants were recruited. Those who had H. pylori infections had higher serum HbA1c levels and lower HOMA-B than those who did not (5.78% vs. 5.69%, P = 0.01 and 53.85 + 38.43 vs. 60.64 + 43.40, P = 0.009, respectively). They also had a significantly higher prevalence of type 2 diabetes (8.97% vs. 5.57%, P= 0.02). Chronic H. pylori infection was significantly associated with high levels of HbA1c and type 2 diabetes in participants above 65 years old (P = 0.001) and decreased insulin secretion and sensitivity in those under 45 years (P = 0.05). CONCLUSIONS: Long-term H. pylori infection is significantly associated with high levels of HbA1c and decreased insulin secretion in this Chinese population. Proper screening for H. pylori infection combined with regular monitoring of blood glucose and HbA1c levels might be effective for the early detection of glucose dysregulation and prevention of type 2 diabetes.


Asunto(s)
Diabetes Mellitus Tipo 2/complicaciones , Hemoglobina Glucada/metabolismo , Infecciones por Helicobacter/complicaciones , Helicobacter pylori , Adulto , Anciano , Glucemia/metabolismo , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/prevención & control , Diagnóstico Precoz , Femenino , Infecciones por Helicobacter/sangre , Infecciones por Helicobacter/diagnóstico , Homeostasis/fisiología , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad
6.
J Water Health ; 11(2): 277-80, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23708575

RESUMEN

The purpose of this study was to identify the prevalence of fungal colonization in water systems and to evaluate the effect of decreasing fungal colonization by a copper-silver ionization system. Environmental samples were collected for fungal culture prospectively during a 1-year period (2011-2012) at the study hospital. A total of 392 water samples were examined from five buildings on March 1, 2011 and February 29, 2012. Fungi were isolated in 13 (3.4%) of 392 water samples from five buildings. The prevalence of fungal colonization in buildings was decreased from 4.76% (9/189) to 1.97% (4/203), a reduction of more than 40%, in pre-ionization and post-ionization treatment (p < 0.001). Thirteen (3.4%) of 392 water samples yielded fungi including Fusarium species (n = 7), Penicillium species (n = 2), Scedosporium species (n = 2), Aspergillus species (n = 1), and one unidentifiable mold. The number of isolated Fusarium species in ionized water samples (0.5% (1/203)) was statistically lower than those in nonionized (3.2% (6/189)) (p = 0.003). Our finding may determine if this ionization method can be applied for control of waterborne fungi colonization in hospital water systems.


Asunto(s)
Cobre/farmacología , Hongos/efectos de los fármacos , Plata/farmacología , Abastecimiento de Agua/normas , Cobre/química , Plata/química , Microbiología del Agua
7.
BMC Gastroenterol ; 12: 66, 2012 Jun 08.
Artículo en Inglés | MEDLINE | ID: mdl-22681960

RESUMEN

BACKGROUND: High dose intravenous proton pump inhibitor after endoscopic therapy for peptic ulcer bleeding has been recommended as adjuvant therapy. Whether oral proton pump inhibitor can replace intravenous proton pump inhibitor in this setting is unknown. This study aims to compare the clinical efficacy of oral and intravenous proton pump inhibitor after endoscopic therapy. METHODS: Patients with high-risk bleeding peptic ulcers after successful endoscopic therapy were randomly assigned as oral lansoprazole or intravenous esomeprazole group. Primary outcome of the study was re-bleeding rate within 14 days. Secondary outcome included hospital stay, volume of blood transfusion, surgical intervention and mortality within 1 month. RESULTS: From April 2010 to Feb 2011, 100 patients were enrolled in this study. The re-bleeding rates were 4% (2/50) in the intravenous group and 4% (2/50) in the oral group. There was no difference between the two groups with regards to the hospital stay, volume of blood transfusion, surgery or mortality rate. The mean duration of hospital stay was 1.8 days in the oral lansoprazole group and 3.9 days in the intravenous esomeprazole group (p > 0.01). CONCLUSION: Patients receiving oral proton pump inhibitor have a shorter hospital stay. There is no evidence of a difference in clinical outcomes between oral and intravenous PPI treatment. However, the study was not powered to prove equivalence or non-inferiority. Future studies are still needed. TRIAL REGISTRATION: NCT01123031.


Asunto(s)
2-Piridinilmetilsulfinilbencimidazoles/administración & dosificación , Antiulcerosos/administración & dosificación , Esomeprazol/administración & dosificación , Úlcera Péptica Hemorrágica/prevención & control , Inhibidores de la Bomba de Protones/administración & dosificación , Administración Intravenosa , Administración Oral , Anciano , Transfusión Sanguínea , Endoscopía , Femenino , Humanos , Lansoprazol , Tiempo de Internación , Masculino , Persona de Mediana Edad , Úlcera Péptica/tratamiento farmacológico , Úlcera Péptica/cirugía , Úlcera Péptica Hemorrágica/cirugía , Prevención Secundaria , Resultado del Tratamiento
8.
Scand J Infect Dis ; 44(11): 848-51, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22861146

RESUMEN

BACKGROUND: Colorectal neoplasia is occasionally associated with hepatic abscess. To identify cases, we retrospectively analyzed the medical records of all patients admitted to our hospital for liver abscess from 2004 to 2008. METHODS: Underlying disease was actively sought for all patients. Cases with obvious causes, such as biliary tract obstruction and immunocompromising conditions, were excluded. RESULTS: Out of 211 cases of liver abscess included, 12 were found to be associated with colorectal neoplasia. None of these 12 cases had gastrointestinal symptoms. The stool occult blood test was positive in only 3 cases. There were 3 cases of focal adenocarcinoma in tubulovillous adenoma and the remaining 9 cases all had adenomatous polyps. Complete cure was achieved in all cases. CONCLUSIONS: When managing patients with liver abscess, colorectal neoplasia should be considered as a possible associated underlying condition.


Asunto(s)
Neoplasias Colorrectales/patología , Absceso Piógeno Hepático/patología , Adulto , Anciano , Colonoscopía , Neoplasias Colorrectales/epidemiología , Neoplasias Colorrectales/microbiología , Femenino , Humanos , Absceso Piógeno Hepático/epidemiología , Absceso Piógeno Hepático/microbiología , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Taiwán/epidemiología
9.
Gastrointest Endosc ; 71(7): 1253-9, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20598251

RESUMEN

BACKGROUND: Previous studies showed a correlation between mean withdrawal times during screening colonoscopy and polyp/neoplasia detection rates. OBJECTIVES: To assess the effect of a monitoring and feedback program on withdrawal times, polyp/neoplasia detection rates, and patient satisfaction. DESIGN: Comparison of retrospective and prospective data. SETTING: Teaching hospital. PATIENTS: Asymptomatic adults undergoing screening colonoscopy. INTERVENTIONS: Monitoring and feedback program. MAIN OUTCOME MEASUREMENTS: Withdrawal times, polyp and neoplasia detection rates, and patient satisfaction scores. METHODS: We retrospectively reviewed 850 screening colonoscopies, recording withdrawal times, polyp findings, and patient satisfaction scores. All procedures were performed by 10 experienced gastroenterologists who were then informed that periodic confidential monitoring and feedback of withdrawal times, polyp detection rates, and satisfaction scores would be started. We then prospectively collected data on another 541 screening colonoscopies. We compared pre- and postmonitoring outcome measures. RESULTS: Overall, after monitoring had begun, there was an increase in mean withdrawal times (from 6.57 to 8.07 minutes; P < .0001), and polyp detection rates (from 33.1% to 38.1%; P = .04, significance removed by Bonferroni correction). Nine of the 10 endoscopists increased their withdrawal times significantly. There was a small, nonsignificant increase in the neoplasia detection rate (from 19.6% to 22.7%; P = .17), but no significant change in mean satisfaction scores. Across endoscopists, there was a moderate correlation (r = 0.63; P = .04, significance removed by Bonferroni correction) between withdrawal times and polyp detection rates, but not between withdrawal times and satisfaction scores. LIMITATIONS: No randomization, possible response bias, confounding of intervention effects, and sample size limitations. CONCLUSIONS: Monitoring and feedback are associated with increases in mean withdrawal times and polyp detection rates, but not patient satisfaction scores. Neoplasia detection rates showed a statistically nonsignificant trend toward an increase.


Asunto(s)
Pólipos del Colon/diagnóstico , Colonoscopía/métodos , Retroalimentación Fisiológica , Tamizaje Masivo/métodos , Monitoreo Fisiológico/métodos , Satisfacción del Paciente/estadística & datos numéricos , Pólipos del Colon/epidemiología , Femenino , Estudios de Seguimiento , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Reproducibilidad de los Resultados , Estudios Retrospectivos , Factores de Tiempo , Estados Unidos/epidemiología
10.
Dig Dis Sci ; 55(12): 3473-8, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20397046

RESUMEN

BACKGROUND: Jejunal diverticular disease is a rare cause of gastrointestinal bleeding. The reported incidence of this disease is low in the studies of double-balloon enteroscopy. AIM: The aim of this study was to evaluate the clinical features and management of jejunal diverticular disease, diagnosed by double-balloon enteroscopy, at our institution. METHOD: This was a retrospective study of patients with jejunal diverticular disease conducted from April 2004 to September 2009 at Changhua Christian Hospital. We evaluated the clinical significance of jejunal diverticular disease and the outcome of endoscopic treatment for jejunal diverticular bleeding. RESULTS: From April 2004 to September 2009, a total of 55 patients underwent double-balloon enteroscopy due to obscure gastrointestinal bleeding. Fifteen of these patients were diagnosed with jejunal diverticular disease (8 men and 7 women, mean age 71 years). Four patients were found to have a single diverticulum. Gastrointestinal bleeding was attributed to jejunal diverticular disease in 12 patients. Six patients received endoscopic treatment in order to achieve hemostasis. One patient received emergency surgery due to uncontrolled bleeding. CONCLUSIONS: To our knowledge, this is the first study reporting the clinical significance of jejunal diverticular disease diagnosed by double-balloon enteroscopy. We found that obscure GI bleeding was attributed significantly to jejunal diverticular disease.


Asunto(s)
Divertículo/complicaciones , Divertículo/diagnóstico , Enteroscopía de Doble Balón , Hemorragia Gastrointestinal/etiología , Enfermedades del Yeyuno/complicaciones , Enfermedades del Yeyuno/diagnóstico , Anciano , Anciano de 80 o más Años , Úlcera Duodenal/complicaciones , Úlcera Duodenal/cirugía , Femenino , Humanos , Coagulación con Láser , Masculino , Persona de Mediana Edad , Úlcera Péptica Hemorrágica/cirugía , Estudios Retrospectivos
11.
J Clin Lab Anal ; 24(3): 195-200, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20486202

RESUMEN

Deregulation of insulin-like growth factor-1 (IGF-1) has been implicated in the pathogenesis of several malignancies. This study aimed to investigate the association of changes in circulating IGF-1 with hepatocellular carcinoma (HCC). The radioimmunoassay was used to analyze serum IGF-1 levels of 65 HCC patients and 165 healthy subjects. Serum IGF-1 levels were significantly decreased in the HCC patients as compared with the healthy subjects (158.46+/-105.07 vs. 247.63+/-149.96 ng/mL, P<0.001). Furthermore, insulin resistance was significantly higher in the HCC patients than the healthy subjects (P=0.027). In addition, the significant correlations of serum IGF-1 levels with age and insulin resistance in the healthy subjects were not noted in the HCC patients. Intriguingly, individuals with hepatitis C virus (HCV), not hepatitis B virus, had remarkably decreased IGF-1 levels in both groups of the HCC patients and healthy subjects. Moreover, in the HCV subgroup, serum IGF-1 levels were significantly reduced in the HCC patients than the healthy subjects (113.14+/-71.28 vs. 172.42+/-74.02 ng/mL, P=0.003). In conclusion, decreased serum IGF-1 levels were associated with HCC and the decrease was remarkably noted in those patients concomitant with chronic hepatitis C.


Asunto(s)
Carcinoma Hepatocelular/sangre , Factor I del Crecimiento Similar a la Insulina/análisis , Neoplasias Hepáticas/sangre , Adulto , Anciano , Anciano de 80 o más Años , Envejecimiento/sangre , Alanina Transaminasa/sangre , Fosfatasa Alcalina/sangre , Aspartato Aminotransferasas/sangre , Carcinoma Hepatocelular/complicaciones , Estudios Transversales , Femenino , Hepatitis B/sangre , Hepatitis B/complicaciones , Hepatitis C/sangre , Hepatitis C/complicaciones , Hepatitis Viral Humana/sangre , Hepatitis Viral Humana/complicaciones , Hepatitis Viral Humana/epidemiología , Humanos , Resistencia a la Insulina , Factor I del Crecimiento Similar a la Insulina/metabolismo , Lípidos/sangre , Neoplasias Hepáticas/complicaciones , Masculino , Persona de Mediana Edad , Adulto Joven
12.
South Med J ; 103(12): 1264-8, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21037524

RESUMEN

The use of Yttrium microspheres to treat unresectable hepatoma is increasing worldwide. Therapeutically, Yttrium microspheres show promising increases in survival and tumor response, as well as acceptable toxicities. Here, we report on a 67-year-old man with hepatitis C-related advanced-stage hepatoma. This patient received selective internal radiation therapy (SIRT) using Yttrium microspheres (SIR-Spheres®). The patient displayed bone marrow suppression that resulted in a transient yet profound thrombocytopenia. To our knowledge, this is the first case of a hematologic complication as a consequence of the use of commercially available Yttrium microsphere devices.


Asunto(s)
Carcinoma Hepatocelular/radioterapia , Neoplasias Hepáticas/radioterapia , Microesferas , Trombocitopenia/etiología , Radioisótopos de Itrio/uso terapéutico , Anciano , Humanos , Masculino , Radioisótopos de Itrio/administración & dosificación , Radioisótopos de Itrio/efectos adversos
14.
Eur J Gastroenterol Hepatol ; 20(7): 642-7, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18679066

RESUMEN

OBJECTIVES: Our aim was to measure the prevalence and distribution of colonic neoplasia in Chinese adults, and to estimate the sensitivity of sigmoidoscopic screening strategies for detecting those with advanced neoplasia. METHODS: Asymptomatic, average-risk Chinese adults aged 50 years or older underwent screening colonoscopy. The prevalence and distribution of colonic neoplasia and advanced neoplasia (defined as an adenoma >or=10 mm or with villous, high-grade dysplastic, or malignant features) were reviewed retrospectively and the outcomes of various sigmoidoscopic screening strategies estimated. RESULTS: Of 1,382 individuals (833 men, 549 women; mean age 58.8 years) included, 243 (18%) had colorectal neoplasia and 72 (5.2%) had advanced neoplasia. Neoplasia prevalence was significantly higher in male and older patients. No significant differences were observed in neoplasia distribution between men and women. Overall, 24 patients had advanced neoplasia in the proximal colon, of whom four had synchronous distal neoplasia. The estimated sensitivity for detecting patients with advanced neoplasia was 72% if we assumed screening sigmoidoscopy was performed, with follow-up colonoscopy for those with distal neoplasia; 165 patients would need to undergo colonoscopy. If, instead, we assumed follow-up colonoscopy was done only for patients with distal advanced neoplasia, the estimated sensitivity would decrease slightly to 71%, but the number of colonoscopies would decrease substantially to 51. CONCLUSION: In average-risk Chinese adults, screening sigmoidoscopy is estimated to detect more than two-thirds of patients with advanced neoplasia. In Chinese societies with limited health-care resources, performing colonoscopy only on patients with distal advanced neoplasia is a screening approach that optimizes the return rate on colonoscopic capacity.


Asunto(s)
Pueblo Asiatico/estadística & datos numéricos , Neoplasias Colorrectales/diagnóstico , Sigmoidoscopía/métodos , Adenoma/diagnóstico , Adenoma/etnología , Adenoma/patología , Distribución por Edad , Anciano , Colonoscopía , Neoplasias Colorrectales/etnología , Neoplasias Colorrectales/patología , Métodos Epidemiológicos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Distribución por Sexo , Taiwán/epidemiología
15.
Sci Rep ; 8(1): 10192, 2018 07 05.
Artículo en Inglés | MEDLINE | ID: mdl-29976987

RESUMEN

We studied the combined effect of air pollutant concentrations and meteorological factors [e.g., temperature and atmospheric pressure (AP)] on the acute exacerbation of coronary obstructive pulmonary disease (COPD) in 277 older patients with COPD (240 men and 37 women; average age, 75.3 ± 9.3 years). Average air pollutant concentrations, AP, temperature, and relative humidity corresponding to each of the 7 days before the date of hospitalisation were identified as the case and the two other weekly averages, 4 and 8 weeks prior to admission, were considered the controls. During the warming-up season, COPD exacerbation more likely occurred on days of temperature increase or AP decrease than on other days. Increments in CO, NO2 and O3 concentrations were significantly associated with 5%, 11% and 4% increases in COPD exacerbation risks, respectively. During the cooling-down season, increments in PM10 concentrations were significant risk factors; the exacerbation likely occurred on days of temperature decreases than on other days. Air pollution with increased NO2, CO, O3 and PM10 concentrations and continual temperature changes (colder during cooling-down seasons or hotter during warning-up seasons) were associated with acute exacerbation of COPD in older patients.


Asunto(s)
Contaminantes Atmosféricos/efectos adversos , Monitoreo del Ambiente/estadística & datos numéricos , Hospitalización/estadística & datos numéricos , Enfermedad Pulmonar Obstructiva Crónica/patología , Factores de Edad , Anciano , Anciano de 80 o más Años , Aire/análisis , Contaminantes Atmosféricos/análisis , Contaminación del Aire/efectos adversos , Contaminación del Aire/estadística & datos numéricos , Presión Atmosférica , Estudios Cruzados , Progresión de la Enfermedad , Femenino , Humanos , Masculino , Dióxido de Nitrógeno/análisis , Ozono/efectos adversos , Ozono/análisis , Material Particulado/efectos adversos , Enfermedad Pulmonar Obstructiva Crónica/terapia , Estaciones del Año , Tiempo (Meteorología)
16.
BMJ Open ; 7(1): e014215, 2017 01 23.
Artículo en Inglés | MEDLINE | ID: mdl-28115335

RESUMEN

OBJECTIVES: Metabolic factors are major risk factors for non-alcoholic fatty liver disease although other factors may also contribute to development of fatty liver disease. We explored the association between exposure to soil heavy metals and prevalence of fatty liver disease. METHODS: We retrospectively analysed data from patients diagnosed with fatty liver disease in 2014 at the Health Evaluation Centre of Chang-Hua Christian Hospital (n=1137). We used residency data provided in the records of the Health Evaluation Centre and data for soil metal concentrations from a nationwide survey conducted by the Environmental Protection Administration of Taiwan. We studied the correlations between the severity of fatty liver disease and concentrations of soil heavy metals (arsenic, mercury, cadmium, chromium, copper, nickel, lead and zinc). RESULTS: The prevalence of moderate to severe fatty liver disease in our study was 26.5%. Using univariate and multivariate analysis, we demonstrated that the presence of soil heavy metals was a significant risk factor for fatty liver disease in men (OR 1.83, 95% CI 1.161 to 2.899, p=0.009). With stratification by body mass index (BMI) and gender, lean men with a BMI <24 kg/m2 were the most susceptible to soil heavy metals (OR 5.059, 95% CI 1.628 to 15.728, p<0.05). CONCLUSIONS: Our study suggested a significant association between exposure to soil heavy metals and fatty liver disease in lean men.


Asunto(s)
Metales Pesados/toxicidad , Enfermedad del Hígado Graso no Alcohólico/inducido químicamente , Contaminantes del Suelo/toxicidad , Adulto , Distribución por Edad , Anciano , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Enfermedad del Hígado Graso no Alcohólico/epidemiología , Estudios Retrospectivos , Factores de Riesgo , Factores Socioeconómicos , Taiwán/epidemiología , Adulto Joven
18.
Arch Intern Med ; 165(4): 382-90, 2005 Feb 28.
Artículo en Inglés | MEDLINE | ID: mdl-15738366

RESUMEN

BACKGROUND: Most guidelines for colorectal cancer screening do not consider distal hyperplastic polyps (HPs) to be markers for proximal colon neoplasia. However, many studies have shown an increased risk of proximal neoplasia (PN) in patients with distal HPs. We performed a systematic review to assess the association between distal HPs and PN. METHODS: We identified studies that compared the prevalence of PN and proximal advanced neoplasia in patients with distal HPs vs controls. Two masked investigators extracted data on individuals with distal HPs, distal adenomas, or no distal polyps. Using the DerSimonian and Laird method, we calculated summary risk ratios. Extensive subgroup analysis was performed. RESULTS: The prevalence of PN and proximal advanced neoplasia in persons with distal HPs was 26.0% and 4.4%, respectively. In studies comparing the risk of PN in patients with distal HPs vs those with no distal polyps, the summary risk ratio was 1.81 (95% confidence interval, 1.20-2.73). However, this increased risk disappeared if only high-quality studies on screening patients were considered. The risk ratio was 0.69 (95% confidence interval, 0.60-0.80) when comparing the risk of PN in those with distal HPs vs those with distal adenomas. CONCLUSIONS: Overall, patients with distal HPs have an intermediate risk of PN compared with those with distal adenomas or no distal polyps; however, in asymptomatic screening individuals, there is no increased risk of PN or proximal advanced neoplasia. The discovery of HPs on screening flexible sigmoidoscopy should not automatically prompt follow-up colonoscopy.


Asunto(s)
Adenoma/diagnóstico , Neoplasias del Colon/diagnóstico , Pólipos del Colon/diagnóstico , Adenoma/patología , Adulto , Neoplasias del Colon/patología , Pólipos del Colon/patología , Colonoscopía , Estudios Transversales , Humanos , Hiperplasia , Persona de Mediana Edad , Oportunidad Relativa , Prevalencia , Estudios Retrospectivos , Factores de Riesgo
19.
JAMA ; 295(20): 2357-65, 2006 May 24.
Artículo en Inglés | MEDLINE | ID: mdl-16720821

RESUMEN

CONTEXT: Current guidelines do not include an upper age cutoff for colorectal cancer screening with colonoscopy. Although the prevalence of colonic neoplasia increases with age, life expectancy decreases. Thus, the benefit of screening colonoscopy in very elderly patients may be limited. OBJECTIVE: To compare estimated life-years saved with screening colonoscopy in very elderly vs younger persons. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional study conducted among 1244 asymptomatic individuals in 3 age groups (50-54 years [n = 1034], 75-79 years [n = 147], and > or =80 years [n = 63]) who underwent screening colonoscopy at a US teaching hospital and clinic. MAIN OUTCOME MEASURES: Prevalence of various types of colon neoplasia; estimated gain in life expectancy, calculated as life expectancy--(life expectancy during polyp lag time + life expectancy after colorectal cancer diagnosis); and comparison of mean gain in life expectancy across the 3 groups. Life expectancy and mortality data were derived from life tables, previous studies, and national databases. RESULTS: The prevalence of neoplasia was 13.8% in the 50- to 54-year-old group, 26.5% in the 75- to 79-year-old group, and 28.6% in the group aged 80 years or older. Despite higher prevalence of neoplasia in elderly patients, mean extension in life expectancy was much lower in the group aged 80 years or older than in the 50- to 54-year-old group (0.13 vs 0.85 years). In sensitivity analysis, with longer polyp lag times the mean extension in life expectancy decreased more in the elderly than in the younger patients; alternatively, if it was assumed that a smaller proportion of adenomas progress to colorectal cancer, the mean extension in life expectancy decreased less in the elderly than in the younger patients. CONCLUSIONS: Even though prevalence of neoplasia increases with age, screening colonoscopy in very elderly persons (aged > or =80 years) results in only 15% of the expected gain in life expectancy in younger patients. Screening colonoscopy in very elderly patients should be performed only after careful consideration of potential benefits, risks, and patient preferences.


Asunto(s)
Colonoscopía , Neoplasias Colorrectales/diagnóstico , Neoplasias Colorrectales/epidemiología , Esperanza de Vida , Anciano , Anciano de 80 o más Años , Estudios Transversales , Femenino , Humanos , Masculino , Tamizaje Masivo , Persona de Mediana Edad , Prevalencia
20.
Vaccine ; 34(50): 6316-6322, 2016 12 07.
Artículo en Inglés | MEDLINE | ID: mdl-27823899

RESUMEN

OBJECTIVE: Air pollution, weather condition and influenza are known risk factors of acute coronary syndrome (ACS) among elderly people. The influenza vaccine (IV) has been shown to reduce major cardiovascular events. The purpose of this study was to compare resistance to air pollution and weather factors causing ACS between vaccinated and less-vaccinated elderly people. METHODS: A case-crossover design was applied to 1835 elderly ACS patients who were obtained from the 1-million sample of Taiwan National Health Insurance Research Data with inclusion criteria: (1) the first diagnosis of ACS was in cold season and at age 68 or more, (2) had received the free IV program at least once during the period 3years before the ACS. They were stratified into two groups: 707 had received flu vaccinations for all the 3years and the remaining 1128 had not. The measurements of air pollutants, temperature, and humidity corresponding to each of the 3days prior to the ACS diagnosis date were retrieved from the data banks of the Taiwan Environmental Protection Administration and Central Weather Bureau. FINDINGS: Increases in air pollution concentrations of CO, NO2, PM10 or PM2.5 and decreases in temperature significantly influenced the risk of ACS for the non-continuously vaccinated elderly population; however, less significant effects were observed for the continuously vaccinated population. CONCLUSION: Consecutive influenza vaccination may potentially offer resistance against the detrimental effects of air pollution and changes in temperature in frail elderly adults with ACS. Future studies are needed to directly assess the interaction effect between the vaccination and environmental factors on ACS.


Asunto(s)
Síndrome Coronario Agudo/epidemiología , Síndrome Coronario Agudo/prevención & control , Contaminación del Aire/efectos adversos , Vacunas contra la Influenza/administración & dosificación , Vacunas contra la Influenza/inmunología , Gripe Humana/complicaciones , Gripe Humana/prevención & control , Anciano , Anciano de 80 o más Años , Estudios Cruzados , Femenino , Humanos , Humedad , Masculino , Taiwán/epidemiología , Temperatura
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA